Supriya Lifescience Limited SUPRIYA.NS · Stock Open Supriya Lifescience Limited in new tab
Analyst price targets
Recent rating changes, newest first
Supriya Lifescience Limited Analysis (SUPRIYA.NS)
Is Supriya Lifescience Limited a good investment? Supriya Lifescience Limited (SUPRIYA.NS) is currently trading at 859.90 INR. Market analysts have a consensus price target of 940.00 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 34.37. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Supriya Lifescience Limited is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is 38.80.
For income investors, Supriya Lifescience Limited pays a dividend yield of 0.12%.
Investor FAQ
Does Supriya Lifescience Limited pay a dividend?
Yes, it pays an annual dividend of 1.00 INR (0.12% yield).
What asset class is Supriya Lifescience Limited?
Supriya Lifescience Limited is classified as a Stock.
When is the next earnings date?
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of 24.65.
Company Profile
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals in India and internationally. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antihypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides finished formulation products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it develops drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.17 INR
|
| Oct. 25, 2027 (estimated) | 1.1667 |
| ▸2026 |
1.00 INR
|
| Oct. 24, 2026 | 1.0000 |
| ▸2025 |
1.00 INR
|
| Oct. 24, 2025 | 1.0000 |
| ▸2024 |
0.80 INR
|
| Oct. 26, 2024 | 0.8000 |
| ▸2023 |
0.60 INR
|
| Oct. 29, 2023 | 0.6000 |
| ▸2022 |
0.60 INR
|
| Oct. 16, 2022 | 0.6000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Supriya Lifescience Limited | Oct 24, 2026 | Paid | 1.0 INR |
Community Discussion